|
|
|
|
|
|
Year: 2023 Vol. 27 Num. 1 -
Jan/Mar
DOI: 10.1055/s-0042-1758716
|
Print: |
|
|
|
|
Anosmia in COVID-19 Patients: Can We Predict the Severity of Chest Manifestations? |
|
How to cite this article |
Hendawy E, El-anwar MW, Elghamry RM, Abdallah AM, Ibrahim AM. Anosmia in COVID-19 Patients: Can We Predict the Severity of Chest Manifestations?. Int. Arch. Otorhinolaryngol. 2023;27(1):e143-e151 |
|
Author(s): |
Ehsan Hendawy, Mohammad Waheed El-Anwar, Reda M. Elghamry, Amany M. Abdallah, Amin M. Ibrahim
|
|
|
Key words: |
anosmia - COVID-19 - chest disease |
|
|
|
Abstract: |
Introduction Anosmia is one of the common symptoms of COVID-19, the link between severity of chest infection and anosmia was investigated by few studies.
Objectives To find an association between anosmia and severity of chest infection.
Methods An analysis of patients admitted to isolation hospital of our university with confirmed polymerase chain reaction positive testing for COVID-19, between March 2021 until September 2021. We called all patients who reported anosmia during their time of illness and asked them about anosmia. We examined their chest CT. A statistical analysis was done.
Results A total of 140 patients completed the study; 65% were female and 56.4% had complete anosmia. Anosmia was significantly associated with loss of taste. Smell returned in 92.5% of anosmic patients. Duration of smell loss was ∼ 2 weeks in 40.5%. The most common symptoms associated with anosmia were running nose, sore throat, fever, and cough. Loss of smell was significantly associated with mild chest disease. 73.4% of anosmic patients had mild chest infection, 21.5% of them had moderate infection, and 5.1% had severe chest infection.
Conclusion The pattern of anosmia in COVID-19 patients has some common similarities in general; the way it starts, the associated symptoms, the time until smell returns and, the most important, the severity of chest infection. As anosmia is significantly associated with mild chest infection. the presence of anosmia could be an independent predictor of good COVID-19 outcome as reflected by a lower disease severity and less frequent ICU admissions.
|
|
|
|
|
|
|
Print: |
|
|
|
|
|
|
|
All right reserved. Prohibited the reproduction of papers
without previous authorization of FORL © 1997-
2024
|
|
|
|
|